Product Code: ECCO4R2iMIND
Caring for Patients With Renal Disorders: Part 2
Subscription Length - 6 months
Summary
Renal, Part 2 provides an in-depth overview of the principles of renal replacement therapy (RRT) for the patient experiencing continuous renal replacement therapy (CRRT). Topics include evaluating CRRT orders based on patient condition, transport mechanisms in CRRT, assessing and troubleshooting the CRRT circuit, calculating fluid removal rates and ensuring patient safety. Within each topic area, you will explore measures to intervene for alterations and prevent complications.
Learning Objectives
- Review the common considerations for patients with progressive renal dysfunction and the use of renal replacement therapies.
- Provide care for a virtual patient on continuous renal replacement therapy (CRRT). Manage potential complications for patients receiving CRRT.
Derived From ECCO
The contents of this modular course are from “Essentials of Critical Care Orientation” (ECCO) 4.0’s ICU track.
Designed for nurses new to working in progressive or intensive care units, ECCO applies current, evidence-based practice to equip learners with the knowledge and confidence to provide safe patient care in the ICU. Featuring evidence-based learning, real-life patient scenarios and virtual simulations, ECCO (ICU) consists of 18 modules that offer up to 75.45 continuing education (CE) contact hours.
Purchase full course.
Access for Multiple Learners
For more information about purchasing for multiple learners, visit course pricing for organizations.
Disclosures
CE hours are provided for this ECCO modular course.
The American Association of Critical-Care Nurses (AACN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation, Provider Number 0012. The American Association of Critical-Care Nurses is approved by the California State Board of Registered Nursing, Provider Number CEP1036, for up to 2.83 contact hours.
CE Expiration Date: July 1, 2026.
This product is nonrefundable.
